TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.
|
|
- Doreen Barton
- 6 years ago
- Views:
Transcription
1 Number of Companies consisting of Market Share of 1% & Above Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 2 Average PTR Add : 16% Retailer Margin 2.06 Ceiling Price (without local taxes) % Reduction with compared to Highest Price 8.14% WPI Reduction wef % 0.40 WPI Increase wef % 0.29 Final Ceiling Price ( wef or date of notification, whichever is later) S. No. Unique No. as per Composition as per Minimum Price S.O. 619(E) dated Maximum Price Ceiling Price as per Per ML Average of all considered Derived Ceiling PTR Ceiling Price TOTAL MAT 1,52,81, % Unit PTR MAT SKU wise ADRENALINE C1C3 DIANORA 1 MG INJECTION 2 ML DIANORA CACHET PHARMACEUTICALS PVT LTD 1 MG 2 ML , % N EPINEPHRINE C1C2 VASOCON 1 MG INJECTION 1 ML VASOCON NEON LABORATORIES LTD 1 MG 1 ML ,27,03, % Y EPINEPHRINE C1C2 EPITRATE 1 MG INJECTION 1 ML EPITRATE SUNWAYS (INDIA) PVT LTD 1 MG 1 ML ,65, % Y Unit Unit
2 S.N o. Sum of MAT value considered for price calculation (in Lakhs) Pheniramine Injection mg/ml Per ML Sum of PTR per unit considered for price calculation 1.25 Number of s considered 1 Average PTR 1.25 Add : 16% Retailer Margin 0.20 Ceiling Price (without local taxes) 1.45 % Reduction with compared to Highest Price 0.00% WPI Reduction wef % 0.04 WPI Increase wef % 0.03 Final Ceiling Price ( wef or date of notification, whichever is later) 1.44 Unique Composition as per No. as per Minimumum Price 1.25 S.O. 836(E) dated Maximum Price 1.25 Ceiling Price as per 2011 (wef ) 1.45 Per ml Average of all considered 1.25 Derived Ceiling PTR 1.25 Ceiling Price 1.45 TOTAL MAT 9,10,00, % Unit PTR MAT SKU wise PHENIRAMINE R6A17 AVIL MG INJECTION 2 ML AVIL SANOFI INDIA LTD MG 2 ML ,10,00, % Y Unit Unit
3 S.N o. Sum of MAT value considered for price calculation (in Lakhs) 1, Pheniramine Injection mg/ml Per ML Sum of PTR per unit considered for price calculation 0.92 Number of s considered 1 Average PTR 0.92 Add : 16% Retailer Margin 0.15 Ceiling Price (without local taxes) 1.07 % Reduction with compared to Highest Price 0.00% WPI Reduction wef % 0.03 WPI Increase wef % 0.02 Final Ceiling Price ( wef or date of notification, whichever is later) 1.06 Unique Composition as per No. as per Minimumum Price 0.92 S.O. 836(E) dated Maximum Price 0.92 Ceiling Price as per 2011 (wef ) 1.45 Per ml Average of all considered 0.92 Derived Ceiling PTR 1.25 Ceiling Price 1.07 TOTAL MAT 14,38,82, % Unit PTR MAT SKU wise PHENIRAMINE R6A17 AVIL MG INJECTION 10 ML AVIL SANOFI INDIA LTD MG 10 ML ,38,82, % Y Unit Unit
4 S. No. Number of Companies consisting of Market Share of 1% & Above Sodium valproate Tablet 200 mg Per Tablet Sum of MAT value considered for price calculation (in Lakhs) 1, Sum of PTR per unit considered for price calculation Number of s considered 7 Average PTR 2.54 Add : 16% Retailer Margin 0.41 Ceiling Price (without local taxes) 2.95 % Reduction with compared to Highest Price 9.93% WPI Reduction wef % 0.08 WPI Increase wef % 0.06 Final Ceiling Price ( wef or date of notification, whichever is later) 2.93 Unique Composition as per No. as per Minimum Price 1.61 S.O. 619(E) dated Maximum Price 2.82 Ceiling Price as per Per Tablet Average of all considered 2.54 Derived Ceiling PTR 2.92 Ceiling Price 2.95 TOTAL MAT 19,72,86, % Unit PTR MAT SKU wise Brandwise MAT (ignoring O% MAT) SODIUM VALPROATE N3A14 EPILEX EC 200 MG TABLET 10 EPILEX ABBOTT INDIA LTD. 200 MG 10 TABLET ,70, % 11.99% Y SODIUM VALPROATE N3A14 EPILEX 200 MG TABLET 10 EPILEX ABBOTT INDIA LTD. 200 MG 10 TABLET ,31,80, % 11.99% Y SODIUM VALPROATE N3A14 AMVALOR CHRONO 200 MG TABLET 10 AMVALOR CHRONO ARINNA LIFESCIENCES PVT. LTD 200 MG 10 TABLET , % 0.01% N SODIUM VALPROATE N3A14 VALTEC 200 MG TABLET 10 VALTEC CIPLA LTD. 200 MG 10 TABLET , % 0.01% N SODIUM VALPROATE N3A14 KRONOSTAR 200 MG TABLET 10 KRONOSTAR LUPIN LTD 200 MG 10 TABLET ,45, % 1.04% Y SODIUM VALPROATE N3A14 VALCONTIN 200 MG TABLET 10 VALCONTIN MODI MUNDI PHARMA PVT LTD 200 MG 10 TABLET , % 0.03% N SODIUM VALPROATE N3A14 NAVALIN 200 MG TABLET 10 NAVALIN MOLEKULE (IND)PVT LTD 200 MG 10 TABLET , % 0.02% N SODIUM VALPROATE N3A14 VALPARIN 200 MG TABLET 10 VALPARIN SANOFI INDIA LTD. 200 MG 10 TABLET ,83,79, % 65.07% Y SODIUM VALPROATE N3A14 SENVAL 200 MG TABLET 10 SENVAL SUN PHARMA (RANBAXY LABORATORIES LTD) 200 MG 10 TABLET , % 0.01% N SODIUM VALPROATE N3A14 EPIVAL EC 200 MG TABLET 10 EPIVAL SUN PHARMA (RANBAXY LABORATORIES LTD) 200 MG 10 TABLET ,32,38, % 6.71% Y SODIUM VALPROATE N3A14 ENCORATE 200 MG TABLET 10 ENCORATE SUN PHARMA (RANBAXY LABORATORIES LTD) 200 MG 10 TABLET ,29,90, % 11.65% Y SODIUM VALPROATE N3A14 VALPAREX 200 MG TABLET 10 VALPAREX THEO PHARMA PVT. LTD. 200 MG 10 TABLET ,50, % 0.28% N SODIUM VALPROATE N3A14 TORVATE 200 MG TABLET 10 TORVATE TORRENT PHARMACEUTICALS LTD. 200 MG 10 TABLET ,77, % 3.18% Y Unit Unit
5 Computation of Ceiling Price based on Aug 2015 Data under Para 6 of DPCO Phenobarbitone Tablet 30 mg Per Tablet Sum of MAT value considered for price calculation (in Lakhs) PTR under Consideration 1.23 % Reduction with compared to Highest Price (average) 17.86% Reduction as per Monopoly condition 0.22 PTR after Reduction 1.01 Add : 16% Retailer Margin 0.16 Ceiling Price (without local taxes) 1.17 WPI Reduction wef % 0.03 S.O. 582(E) dated WPI Increase wef % 0.02 Ceiling Price as per Per Tablet Final Ceiling Price ( wef or date of notification, whichever is later) 1.16 Derived Ceiling PTR 1.41 A. List of Item Under consideration TOTAL MAT 6,82,89,995 S. No. Composition as per Unique No. as per Unit PTR MAT MAT (%) Unit PHENOBARBITONE N3A10 GARDENAL 30 MG TABLET 30 GARDENAL ABBOTT HEALTHCARE PVT. LTD 30 MG 30 TABLET ,72,07, % PHENOBARBITONE N3A10 PHENOBARB 30 MG TABLET 10 PHENOBARB INTAS PHARMACEUTICALS LTD 30 MG 10 TABLET ,90, % 3 PHENOBARBITONE N3A10 EMGARD 30 MG TABLET 10 EMGARD MEDO PHARMA 30 MG 10 TABLET ,72, % 4 PHENOBARBITONE N3A10 EPITAN 30 MG TABLET 10 EPITAN RELIANCE FORMULATION PVT LTD 30 MG 10 TABLET ,19, % B. Computation of Average rate of Reduction under Monopoly S. No. Drug(s) Description Route of Administrati on/ Dosage Form & packsize/pa cking, if any S.O. number & date Reduction with reference to the highest PTR under 2015 (%) 1 Phenobarbitone 60 mg tablet 1951(E) dated Phenobarbitone 20 mg/ 5 ml Oral Liquid 443 (E) dated Phenobarbitone 200mg/ ml Injection 2730(E) dated Average Reduction 17.86
Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
More informationORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
More informationNPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,
What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
More informationRESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
More informationORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
More informationWhat s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
More informationORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
More informationNew Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
More informationTHE DRUGS (PRICES CONTROL) ORDER, 2013
THE DRUGS (PRICES CONTROL) ORDER, 2013 (Notified by SO 1221 (E) dated 15.05.2013 and as amended up to vide SO 1192(E) dated 22-03-2016) In exercise of the powers conferred by section 3 of the Essential
More informationSubject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
More informationORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
More informationMinistry of Chemicals and Fertilizers. (Department of Pharmaceuticals) ORDER
Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) New Delhi, Dated 15th May 2013 ORDER S.O. 1221(E). In exercise of the powers conferred by section 3 of the Essential Commodities Act,
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,
More informationSTATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, Pack Size. Vial.
1 STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, 2001 Agenda Item No. Company Name/ Formulation Name/Composition Pack Size Existing Price RP
More informationCase 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023
Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,
More informationInformation for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationLETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)
More informationMinimumum Price (Rs.) 6.93 Maximum Price (Rs.) Average of all considered (Rs.) 8.97 Retail Price (Rs.) 10.41
S. No. Computataion of Retail Price based on May, 2016 Data under Para 4 of DPCO 2013 ASPIRIN 75mg + ROSUVASTATIN 10mg + CLOPIDOGREL 75mg Tablet of M/s Safetab Life Science/M/s Intas Pharmaceuticals Ltd.
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
More informationThe Gazette of the Democratic Socialist Republic of Sri Lanka
I fldgi ( ^I& fpoh - YS%,xld m%cd;dka;s%l iudcjd ckrcfha w;s úfyi.eiü m;%h - 2016'10'21 1A Y%S,xld m%cd;dka;%sl iudcjd ckrcfha.eiü m;%h w;s úfyi The Gazette of the Democratic Socialist Republic of Sri
More informationTo be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15 th May 2013 ORDER
To be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15 th May 2013 Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) New Delhi Dated 15
More informationFile no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
More informationGlobal Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
More informationInformation for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationREGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More information10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE
10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting
More informationTODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
More informationBudesonide equivalent dosing
Budesonide equivalent dosing dosage, adverse reactions, pharmacology and more. Budesonide 0.5mg Nebuliser Suspension (Breath Ltd) - Summary of Product Characteristics (SmPC) by Actavis UK Ltd 11-9-2012
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS
More informationDisclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations
49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a
More informationDecentralised Procedure. Public Assessment Report
Bundesinstitut für Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report Clozapin Regiomedica 50 mg/ml Suspension zum Einnehmen Clozamedica 50 mg/ml Suspension zum Einnehmen
More informationPublic Assessment Report Scientific discussion. Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC
Public Assessment Report Scientific discussion Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC This module reflects the scientific discussion for the approval of Ciprofloxacin Accord.
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
More informationInformation for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
More informationMEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS. PHM154A September Anand Gijare Project Analyst ISBN:
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS PHM154A September 2013 Anand Gijare Project Analyst ISBN: 1-56965-544-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationNo.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the NOTIFICATION. In supersession of this Department s Office Order of even number
Government of Himachal Pradesh Department of Ayurveda No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the 31-8-2009 NOTIFICATION In supersession of this Department s Office Order of even number dated 5 th February,
More informationInformation for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)
Information for Vermont Prescribers of Prescription Drugs Lunesta (eszopiclone tablets) This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.
More informationList Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)
Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version
More informationFree Trial Future Generics Database
API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide
More informationGlobal Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023 Global Psoriasis Pipeline Drugs Industry Sizing, Growth and Forecast
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the
More informationPalliative Coverage Drug Benefit Supplement
Palliative Coverage Drug Benefit Supplement Effective April 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
More informationA study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
More informationDrug Quality in Generics, Substandard Drugs & Copies
Drug Quality in Generics, Substandard Drugs & Copies Atholl Johnston Professor of Clinical Pharmacology 2 Preamble Health expectations must be matched with available resources Not here to dismiss generic
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
More informationMEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
More informationCountry Coverage. Company Coverage
Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon
More informationreductions Untangling the web of price reductions: eligibility pricecountries company price countries price
company price countries reductions pricecountries price eligibility reductions Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries 1st December 2003
More informationAppendix 3 Administration of Covert Medication Review Form
Appendix 3 Administration of Covert Medication Review Form Name of service user Date of birth Date review performed Is medication still necessary? If so, explain why Is covert administration still necessary?
More informationongoing Insulin degludec/liraglutid 1 daily ongoing x daily
Resolution by the Federal Joint Committee on an amendment to the Pharmaceutical Directive (AM-RL): Appendix XII Resolutions on the benefit assessment of pharmaceuticals with new active ingredients, in
More informationreductions Untangling the web of price reductions: 6th Edition eligibility pricecountries company price countries price
company price countries reductions pricecountries price eligibility reductions Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries 6th Edition 19th
More informationMutual Recognition Procedure. Public Assessment Report. Valproat Orion 300 / 500 mg Retardtabletten. Sodium valproate DE/H/1910/ /MR
Mutual Recognition Procedure Public Assessment Report Valproat Orion 300 / 500 mg Retardtabletten Sodium valproate DE/H/1910/001-002/MR (former FI/H/0608/001-002/MR) Applicant: Orion Corporation Date:
More informationPublic Assessment Report Scientific discussion. Mycophenolic Acid Accord Healthcare 180 mg and 360 mg gastro-resistant tablets. Mycophenolate sodium
Public Assessment Report Scientific discussion Mycophenolic Acid Accord Healthcare 180 mg and 360 mg gastro-resistant tablets Mycophenolate sodium ES/H/0275/001-002/DC Applicant: Accord Healthcare Limited
More informationMinimum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Ceiling Price (Rs.)
Computation of Ceiling based on Aug-2015 Data under Para 4 of DPCO 2013 8.1.34 Temozolomide 250mg Tabs Per Tablet Number of Companies consisting of Market Share of 1% & Above 2 Sum of MAT value considered
More informationDosing Information. The First & Only FDA-approved Spironolactone Oral Suspension P HARM A. Exclusively from
Dosing Information The First & Only FDA-approved Spironolactone Oral Suspension Exclusively from P HARM A The Formulation That s Easy To Prescribe CAROSPIR is an antagonist of aldosterone indicated for:
More informationChina Oral Hypoglyceimic Agents (OHAs) Industry Report, Feb. 2011
China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010 Feb. 2011 This report Analyzes the status quo and prospect of Chinese OHAS Market. Related Products China Interventional Cardiovascular Device
More informationCost analysis of antifungal drugs available in India: A pharmacoeconomic perspective
Original Research Article DOI: 10.18231/2393-9087.2016.0013 Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective Ashutosh Tiwari 1,*, Pooja Reddy 2, Chhaya Goyal 3 1 Tutor,
More informationMOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan-
MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- This material is an English translation of the press release issued on November 29, 2018 in Japanese,
More informationMOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan-
November 29, 2018 EA Pharma Co., Ltd. Eisai Co., Ltd. Mochida Pharmaceutical Co., Ltd. MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- EA Pharma
More informationPublic Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended.
Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Bricanyl () DK/W/0017/pdWS/001 Rapporteur: Denmark Finalisation procedure
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
More informationNitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
More informationUSP Chewable Gels Monographs
USP Dietary Supplements Stakeholder Forum Tuesday, May 15, 2018 USP Chewable Gels Monographs Natalia Davydova, Ph.D. Scientific Liaison DS Gummies Market Value of the gummy vitamins market in the United
More informationSIMULTANEOUS ESTIMATION OF LEVOCETIRIZINE DIHYDROCHLORIDE AND MONTELUKAST SODIUM BY RP-HPLC METHOD
SIMULTANEOUS ESTIMATION OF LEVOCETIRIZINE DIHYDROCHLORIDE AND MONTELUKAST SODIUM BY RP-HPLC METHOD 1 1 Sushma Somkuwar, A.K. Pathak * Department of Pharmacy, Barkatullah University, Bhopal, M.P., [India]
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010, 2(2): 294-299 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationAZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF
AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF Azithromycin 250 Mg Treatment For Toothache Pain Relief Seeing azithromycin 250 mg Azithromycin tablets ip 500 mg for acne Does azithromycin affect
More informationLegal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
More informationKampo Formulations for Prescription Information in Package Inserts of 148 Formulations - 1 Dec 2018
Kampo Formulations for Prescription 2018 - Information in Package Inserts of 148 Formulations - 1 Dec 2018 Usability Research Subcommittee Ethical Kampo Products Committee Japan Kampo Medicines Manufacturers
More informationElectronic Prescription Service (EPS) dm+d and Prescribing Systems
Electronic Prescription Service (EPS) dm+d and Prescribing Systems dm+d and Prescribing Systems The NHS Dictionary of Medicines and Devices (dm+d) is the standard for transferring medicine and medical
More informationRecommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division
Recommetions of thesec (Dermatology & Allergy) made in its 23 rd meeting held on 11.05.2017 at CDSCO HQ New Delhi: File /Drug Name Recommetions New Drugs Division 1 12-28/15-DC (Pt-B) Apremilast 10/20/30
More informationQuality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro
Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices
More information+91-8042964906 Streamline Pharma Private Limited http://www.herbalmedicinesonline.in/ With the support of vast knowledge, we are recognized as a noteworthy manufacturer, supplier and service provider of
More informationModified release drug delivery system for antiepileptic drug (Formulation development and evaluation).
TITLE OF THE THESIS / RESEARCH: Modified release drug delivery system for antiepileptic drug (Formulation development and evaluation). INTRODUCTION: Epilepsy is a common chronic neurological disorder characterized
More informationOF NOTIFIED CEILING PRICES OF SCHEDULED DRUGS
ISO 9001 : 2008 Certified Affordable Medicine for All COMPENDIUM OF NOTIFIED CEILING PRICES OF SCHEDULED DRUGS (AS ON 31ST JANUARY, 2015) National Pharmaceutical Pricing Authority Department of Pharmaceuticals
More information+91-8048607449 Neuracle Lifesciences Private Limited http://www.neuraclelifesciences.com/ We are a leading organization engrossed in trading and wholesaling an effective array of Pharmaceutical Medicines.
More informationdiclofenac, 75mg/2ml of solution for intravenous injection (Dyloject ) No. (446/08) Javelin Pharmaceuticals UK Ltd
Scottish Medicines Consortium diclofenac, 75mg/2ml of solution for intravenous injection (Dyloject ) No. (446/08) Javelin Pharmaceuticals UK Ltd 11 February 2008 The Scottish Medicines Consortium has completed
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationAbstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *
International Journal of ChemTech Research ISSN : 0974-4290 Vol.1,No.1,pp 16-26, Jan March 2009 A Validated Specific Reverse Phase Liquid Chromatographic Method for the Determination of Valacyclovir in
More informationFormulary and Prescribing Guidelines
Formulary and Prescribing Guidelines SECTION 3: TREATMENT OF BIPOLAR AFFECTIVE DISORDER This section provides information regarding the pharmacological management of Bipolar affective disorder in secondary
More informationMEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
More informationEurope Ginseng Market Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Europe Ginseng Market Report 2016 Europe Ginseng Market Report 2016 Publication ID: QYR12167206 Publication December
More informationPierre Legault CEO June 2, 2014
April 2012 Pierre Legault CEO June 2, 2014 Forward Looking Statements This presentation includes statements that are, or may be deemed, forward-looking statements. In some cases, these forward-looking
More informationWhat is the lowest dose of depakote
What is the lowest dose of depakote The Borg System is 100 % What is the lowest dose of depakote Oral dosage (delayed-release divalproex (Depakote), valproic acid (Depakene), or delayed-release valproic
More information